Interview with Justus Stenzig MD, PhD, Research Group Leader, Dept of Experimental Pharmacology and Toxicology, 
University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dr. Stenzig's article <a href='https://www.jmcc-online.com/article/S0022-2828(21)00031-6/fulltext'>Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes</a> is a JMCC Editor's Choice selection.

Interview with Justus Stenzig MD, PhD, Research Group Leader, Dept of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Dr. Stenzig's article Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes is a JMCC Editor's Choice selection.

Interview with Justus Stenzig MD, PhD, Research Group Leader, Dept of Experimental Pharmacology and Toxicology, 
University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dr. Stenzig's article <a href="https://www.jmcc-online.com/article/S0022-2828(21)00031-6/fulltext" rel="noopener noreferrer">Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes</a> is a JMCC Editor's Choice selection.&nbsp;

Scientist in the Spotlight: Justus Stenzig

Podcast featuring interviews with authors published in the Journal of Molecular and Cellular Cardiology

Share Scientist in the Spotlight: Justus Stenzig

Sign up to save your podcasts

Scientist in the Spotlight: Justus Stenzig

Scientist in the Spotlight: Justus Stenzig